期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 85, 期 5, 页码 548-552出版社
WILEY
DOI: 10.1038/clpt.2008.295
关键词
-
资金
- Meijer Lavino Foundation for Cardiac Research, Aalst, Belgium
Stem cell-based cardiovascular regenerative medicine offers the next frontier of therapy through delivery of progenitor cells to achieve structural and functional repair of the myocardium. Initial clinical experience indicates that such therapy is feasible and safe, yet structural and functional benefits remain rather modest. A common pitfall in all studies is the very low rate of cell retention by the recipient myocardial tissue. This limitation warrants lead optimization so as to improve the outcome of stem cell delivery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据